Essex Investment Management CO LLC Travere Therapeutics, Inc. Transaction History

Essex Investment Management CO LLC

  • $536 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$22.91 - $28.63 $96,726 - $120,875
4,222 Added 7.91%
57,605 $1.42 Million
Q2 2022

Aug 12, 2022
SELL
$20.94 - $30.01 $15,349 - $21,997
-733 Reduced 1.35%
53,383 $1.29 Million
Q1 2022

May 09, 2022
BUY
$23.61 - $30.6 $90,072 - $116,739
3,815 Added 7.58%
54,116 $1.4 Million
Q4 2021

Feb 10, 2022
BUY
$24.34 - $31.17 $1.22 Million - $1.57 Million
50,301 New
50,301 $1.56 Million

Others Institutions Holding TVTX

# of Institutions
198
Shares Held
84.9M
Call Options Held
776K
Put Options Held
912K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.3B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email